Authors:
Scheding, S
Meister, B
Buhring, HJ
Baum, CM
McKearn, JP
Bock, T
Kanz, T
Brugger, W
Citation: S. Scheding et al., Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells, EXP HEMATOL, 28(4), 2000, pp. 460-470
Authors:
Kratz-Albers, K
Scheding, S
Mohle, R
Buhring, HJ
Baum, CM
Mc Kearn, JP
Buchner, T
Kanz, L
Brugger, W
Citation: K. Kratz-albers et al., Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin, EXP HEMATOL, 28(3), 2000, pp. 335-346
Authors:
Kanz, L
Brossart, P
Stuhler, G
Reichardt, V
Kleihauer, A
Scheding, S
Stevanovic, S
Einsele, H
Rammensee, HG
Brugger, W
Citation: L. Kanz et al., Pre-clinical and early clinical experience using dendritic cells to treat human malignancy, HEM CELL TH, 41(2), 1999, pp. 56-57
Authors:
Brugger, W
Buhring, HJ
Grunebach, F
Vogel, W
Kaul, S
Muller, R
Brummendorf, TH
Ziegler, BL
Rappold, I
Brossart, P
Scheding, S
Kanz, L
Citation: W. Brugger et al., Expression of MUC-1 epitopes on normal bone marrow: Implications for the detection of micrometastatic tumor cells, J CL ONCOL, 17(5), 1999, pp. 1535-1544
Authors:
Scheding, S
Franke, H
Diehl, V
Wichmann, HE
Brugger, W
Kanz, L
Schmitz, S
Citation: S. Scheding et al., How many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation? Results of a computer simulation, EXP HEMATOL, 27(5), 1999, pp. 956-965